Oncology Information Center
Cancer patients with type 2 diabetes may have worse survival outcomes on immune checkpoint inhibitor therapy, a new study suggests.
Dermatology Information Center
Cynthia F. Griffith, MPAS, PA-C, and Peter A. Young, MPAS, PA-C, discuss the challenges faced by PAs in dermatology practice.
DrugPrimer
By binding to the regulatory domain of TYK2, deucravacitinib promotes allosteric inhibition of receptor-mediated activation of the enzyme as well as its downstream activation of signal transducers and activators of transcription.
Dermatologic Look-Alikes
Two patients present with suspicious nevi. Can you make the diagnosis?
Dermatology Information Center
A team of international researchers sought to confirm a “dual pathway hypothesis” for the development of melanoma.
Slideshow
Melanoma is the most dangerous type of skin cancer, and the most deadly. It begins in the melanocytes, but may also begin in a mole or in other pigmented tissues, such as the eye. It is estimated that there will be 76,250 new cases of melanoma in the U.S. this year. The number of deaths…
Web Exclusives
One-in-four melanoma survivors report they do not wear sunscreen when going outside on a warm sunny day.
Dermatology Information Center
A strong influence of progestogens used before menopause on melanoma risk was not supported by novel study results, nor do they support a phototoxic effect of progestogens in melanoma risk.
Web Exclusives
Melanoma risk increases with each additional session of sunbed use per year, and for those whose first use was before age 35 years.
Dermatology Information Center
Authors present a concise overview of the diagnosis, risk factors, and treatment of basal cell carcinoma.